Migraine headaches are a common medical condition that causes intensely painful sensations in the head. Migraines are often more debilitating than other kinds of headaches and cause significant disruptions in daily life, completely incapacitating many sufferers. Because they affect the cranial nerves, it is classified as a neurological condition.
Migraines are believed to be triggered by a variety of different things such as hormonal changes, food, stress and even changes in weather. Traditional treatments include medication, diet, and lifestyle changes but a certain percentage of the population still remain unable to prevent migraines. Chronic migraine sufferers endure at least 15 headache days a month, with at least 8 of those days presenting migraine features, for more than 3 months.
Daytryp specializes in employing psychedelic therapies as highly effective and scientifically proven treatment options for individuals suffering from migraines. Our approach offers renewed hope, especially for those who have experienced limited relief from conventional treatments. With a compassionate and knowledgeable team, we guide each client on a transformative healing journey.
Under the careful medical supervision of our experts, our mission is to help you unlock your potential by utilizing psychedelic therapies to address the root causes of migraines. We provide the necessary resources and support to empower you in making lasting changes that promote migraine prevention, alleviate symptoms, and enhance your overall well-being.
At Daytryp Health, we view addiction as part of the larger issue of the current mental health epidemic in America. Out of the 21 million Americans struggling with addiction, approximately 8.5 million suffer from both a mental health issue and a substance use disorder. We understand that often people turn to substances to escape their problems, not because there is something wrong with them. We offer a breakthrough treatment for substance abuse and addiction via Ketamine Assisted Psychotherapy. Click below to learn more.
3,4-methylenedioxy-methamphetamine (MDMA) therapy is an upcoming, highly effective and innovative treatment approach for those suffering from post-traumatic stress disorder (PTSD) and other mental health conditions. It combines the psychoactive compound MDMA with guided psychological support, and has shown as much as a 75% success rate in patients suffering from PTSD, setting an unprecedented standard for treatment. MDMA therapy is not currently available, but expected to gain FDA approval later this year.